Literature DB >> 16449362

Association between PADI4 and rheumatoid arthritis: a meta-analysis.

T Iwamoto1, K Ikari, T Nakamura, M Kuwahara, Y Toyama, T Tomatsu, S Momohara, N Kamatani.   

Abstract

OBJECTIVE: Polymorphisms and haplotypes of the peptidylarginine deiminase type 4 gene (PADI4) have been reported to be associated with rheumatoid arthritis (RA) in a Japanese population. However, subsequent replication studies showed conflicting results. The aim of this study was to determine whether meta-analysis would prove the existence of the association.
METHODS: PubMed was searched using the term 'PADI4' for articles from the publication of the first study to December 2005. Replication studies that tested the association between PADI4 and RA were reviewed for meta-analysis. The Breslow-Day test for homogeneity across the studies was calculated. The Mantel-Haenszel procedure was used to pool odds ratios (OR) with 95% confidence intervals (CI) to evaluate the association.
RESULTS: Six replication studies, one from Japan and five from Europe and North America, fulfilled the selection criteria for inclusion in the meta-analysis. Homogeneity was confirmed across the replication studies. The common OR was 1.14 (95% CI = 1.07-1.21) for allelic distribution. The association was confirmed when only five replication studies in the European descent populations were combined (P = 0.0096, common OR = 1.10).
CONCLUSIONS: Our meta-analysis showed a positive association between PADI4 and RA not only in the Japanese population but also in populations of European descent.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16449362     DOI: 10.1093/rheumatology/kel023

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  35 in total

Review 1.  Genetic markers as therapeutic target in rheumatoid arthritis: A game changer in clinical therapy?

Authors:  A M Mohamed Thoufic Ali; S Vino
Journal:  Rheumatol Int       Date:  2016-09-16       Impact factor: 2.631

2.  The development of N-α-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-α-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine amide (o-Cl-amidine) as second generation protein arginine deiminase (PAD) inhibitors.

Authors:  Corey P Causey; Justin E Jones; Jessica L Slack; Daisuke Kamei; Larry E Jones; Venkataraman Subramanian; Bryan Knuckley; Pedram Ebrahimi; Alexander A Chumanevich; Yuan Luo; Hiroshi Hashimoto; Mamoru Sato; Lorne J Hofseth; Paul R Thompson
Journal:  J Med Chem       Date:  2011-09-16       Impact factor: 7.446

Review 3.  Targeting the programmed cell death-1 pathway in rheumatoid arthritis.

Authors:  Sabina Sandigursky; Gregg J Silverman; Adam Mor
Journal:  Autoimmun Rev       Date:  2017-05-29       Impact factor: 9.754

4.  Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.

Authors:  Z Reyes-Castillo; C A Palafox-Sánchez; I Parra-Rojas; G E Martínez-Bonilla; S del Toro-Arreola; M G Ramírez-Dueñas; G Ocampo-Bermudes; José F Muñoz-Valle
Journal:  Clin Exp Immunol       Date:  2015-09-16       Impact factor: 4.330

5.  Phenotypic interpretation of complex chromosomal rearrangements informed by nucleotide-level resolution and structural organization of chromatin.

Authors:  Cinthya J Zepeda-Mendoza; Alexandra Bardon; Tammy Kammin; David J Harris; Helen Cox; Claire Redin; Zehra Ordulu; Michael E Talkowski; Cynthia C Morton
Journal:  Eur J Hum Genet       Date:  2018-01-10       Impact factor: 4.246

Review 6.  [Possibilities and limitations of genomic analyses in rheumatoid arthritis].

Authors:  S Drynda; J Kekow
Journal:  Z Rheumatol       Date:  2009-02       Impact factor: 1.372

7.  Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study.

Authors:  So-Young Bang; Tae-Un Han; Chan-Bum Choi; Yoon-Kyoung Sung; Sang-Cheol Bae; Changwon Kang
Journal:  Arthritis Res Ther       Date:  2010-06-10       Impact factor: 5.156

Review 8.  Developments in the scientific understanding of rheumatoid arthritis.

Authors:  Jörg J Goronzy; Cornelia M Weyand
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156

Review 9.  Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies.

Authors:  Y W Song; E H Kang
Journal:  QJM       Date:  2009-11-19

10.  PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population.

Authors:  Marian L Burr; Haris Naseem; Anne Hinks; Steve Eyre; Laura J Gibbons; John Bowes; Anthony G Wilson; James Maxwell; Ann W Morgan; Paul Emery; Sophia Steer; Lynne Hocking; David M Reid; Paul Wordsworth; Pille Harrison; Wendy Thomson; Jane Worthington; Anne Barton
Journal:  Ann Rheum Dis       Date:  2009-05-25       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.